Anatara Lifesciences (Australia) Today
| ANR Stock | 0.06 0 1.72% |
Performance6 of 100
| Odds Of DistressLess than 47
|
Anatara Lifesciences is selling for under 0.057 as of the 1st of December 2024; that is 1.72 percent decrease since the beginning of the trading day. The stock's last reported lowest price was 0.057. Anatara Lifesciences has 47 percent odds of going through some form of financial distress in the next two years and did not have a very good performance for investor during the last 90 trading days. Equity ratings for Anatara Lifesciences are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 1st of November 2024 and ending today, the 1st of December 2024. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | Category Healthcare | Classification Health Care |
Anatara Lifesciences is entity of Australia. It is traded as Stock on AU exchange. The company has 207.89 M outstanding shares. More on Anatara Lifesciences
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Anatara Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Anatara Lifesciences' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Anatara Lifesciences or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Ex Chairman | FACRRM FAICD |
| Business Concentration | Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, Health Care, Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care (View all Sectors) |
Anatara Lifesciences (ANR) is traded on Australian Securities Exchange in Australia and employs 7 people. Anatara Lifesciences is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Micro-Cap' category with a current market capitalization of 11.85 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Anatara Lifesciences's market, we take the total number of its shares issued and multiply it by Anatara Lifesciences's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Anatara Lifesciences operates under Biotechnology sector and is part of Health Care industry. The entity has 207.89 M outstanding shares.
Anatara Lifesciences generates negative cash flow from operations
Check Anatara Lifesciences Probability Of Bankruptcy
Ownership AllocationAnatara Lifesciences holds a total of 207.89 Million outstanding shares. Anatara Lifesciences retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Anatara Ownership Details
Anatara Lifesciences Risk Profiles
Although Anatara Lifesciences' alpha and beta are two of the key measurements used to evaluate Anatara Lifesciences' performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 3.22 | |||
| Semi Deviation | 3.93 | |||
| Standard Deviation | 5.34 | |||
| Variance | 28.47 |
Anatara Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Anatara Lifesciences without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Stock Screener Now
Stock ScreenerFind equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. |
| All Next | Launch Module |
Anatara Lifesciences Corporate Management
Elected by the shareholders, the Anatara Lifesciences' board of directors comprises two types of representatives: Anatara Lifesciences inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Anatara. The board's role is to monitor Anatara Lifesciences' management team and ensure that shareholders' interests are well served. Anatara Lifesciences' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Anatara Lifesciences' outside directors are responsible for providing unbiased perspectives on the board's policies.
| BSc EMBA | Chief Officer | Profile | |
| Grad Sc | Commercial Manager | Profile | |
| AGIA BCom | Company Sec | Profile | |
| Jane Lowe | Managing Department | Profile | |
| Simon Erskine | Chief Officer | Profile |
Additional Tools for Anatara Stock Analysis
When running Anatara Lifesciences' price analysis, check to measure Anatara Lifesciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Anatara Lifesciences is operating at the current time. Most of Anatara Lifesciences' value examination focuses on studying past and present price action to predict the probability of Anatara Lifesciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Anatara Lifesciences' price. Additionally, you may evaluate how the addition of Anatara Lifesciences to your portfolios can decrease your overall portfolio volatility.